Your email has been successfully added to our mailing list.

×
0.0062189054726369 0.0062189054726369 0.0062189054726369 0.104477611940299 0.0447885572139305 0.0525000000000003 0.0307462686567166 0.0447761194029852
Stock impact report

Urovant Sciences Presents Positive Pivotal Data for Vibegron During Plenary Session at American Urological Association Annual Meeting

UROVANT SCIENCES LTD COMMON (UROV) 
Last urovant sciences ltd common earnings: 2/13 04:15 pm Check Earnings Report
Company Research Source: Business Wire
Pivotal Phase 3 EMPOWUR study met both co-primary endpoints, with significant reduction in daily urge urinary incontinence episodes and micturitions, compared to placebo (p Efficacy observed at week 2 and maintained through week 12 in co-primary endpoints Data showed once-daily 75 mg dose has potential to be an efficacious agent for disruptive overactive bladder symptoms for broad base of patients IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced Dr. David Staskin presented positive, Phase 3 pivotal data demonstrating safety and efficacy of vibegron during a plenary session at the 2019 American Urological Association Annual Meeting (AUA) in Chicago yesterday Show less Read more
Impact Snapshot
Event Time:
UROV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for UROV alerts
Opt-in for
UROV alerts

from News Quantified
Opt-in for
UROV alerts

from News Quantified